Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.
2.
3.

Low-dose warfarin for the prevention of central line-associated thromboses in children with malignancies--a randomized, controlled study.

Ruud E, Holmstrøm H, De Lange C, Hogstad EM, Wesenberg F.

Acta Paediatr. 2006 Sep;95(9):1053-9.

PMID:
16938749
4.

Thromboprophylaxis in cancer patients with central venous catheters. A systematic review and meta-analysis.

Chaukiyal P, Nautiyal A, Radhakrishnan S, Singh S, Navaneethan SD.

Thromb Haemost. 2008 Jan;99(1):38-43. doi: 10.1160/TH07-07-0446. Review.

PMID:
18217132
5.

Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial.

Young AM, Billingham LJ, Begum G, Kerr DJ, Hughes AI, Rea DW, Shepherd S, Stanley A, Sweeney A, Wilde J, Wheatley K; WARP Collaborative Group, UK..

Lancet. 2009 Feb 14;373(9663):567-74. doi: 10.1016/S0140-6736(09)60205-1.

6.

Thromboprophylaxis for catheter-related thrombosis in patients with cancer: a systematic review of the randomized, controlled trials.

Carrier M, Tay J, Fergusson D, Wells PS.

J Thromb Haemost. 2007 Dec;5(12):2552-4. No abstract available.

7.

Catheter-associated thrombosis: thromboprophylaxis or not?

Levine M, Kakkar AK.

J Clin Oncol. 2005 Jun 20;23(18):4006-8. No abstract available.

PMID:
15767646
8.

Prophylaxis of catheter-related venous thrombosis in cancer patients.

Karthaus M.

Support Care Cancer. 2008 Jul;16(7):787-90. doi: 10.1007/s00520-007-0374-0. Review.

PMID:
18274788
9.

Low-dose warfarin prophylaxis for catheter-associated thrombosis in cancer patients. Can it be safely associated with 5-Fluorouracil-based chemotherapy?

Magagnoli M, Castagna L, Masci G, Santoro A.

Oncologist. 2004;9(5):594-5; author reply 596. No abstract available.

10.

Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review.

Klerk CP, Smorenburg SM, Büller HR.

Arch Intern Med. 2003 Sep 8;163(16):1913-21. Review.

PMID:
12963564
11.

Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer.

Couban S, Goodyear M, Burnell M, Dolan S, Wasi P, Barnes D, Macleod D, Burton E, Andreou P, Anderson DR.

J Clin Oncol. 2005 Jun 20;23(18):4063-9.

PMID:
15767639
12.
14.
15.

Systemic anticoagulant prophylaxis for central catheter-associated venous thrombosis in cancer patients.

Chan A, Iannucci A, Dager WE.

Ann Pharmacother. 2007 Apr;41(4):635-41. Review.

PMID:
17355999
16.

Thrombosis prophylaxis in cancer patients with a central venous catheter.

Laporte S, Decousus H, Mismetti P.

Arch Intern Med. 2004 Feb 23;164(4):459; author reply 459-60. No abstract available.

PMID:
14980999
17.

[Management of catheter-related upper extremity deep vein thrombosis].

Linnemann B, Lindhoff-Last E.

Zentralbl Chir. 2013 Dec;138 Suppl 2:e86-94. doi: 10.1055/s-0032-1328098. Review. German.

PMID:
23575524
18.

Prophylaxis of catheter-related thrombosis in cancer patients.

Prandoni P.

Lancet. 2009 Feb 14;373(9663):523-4. doi: 10.1016/S0140-6736(09)60178-1. No abstract available.

PMID:
19217973
19.

Thrombosis-related complications and mortality in cancer patients with central venous devices: an observational study on the effect of antithrombotic prophylaxis.

Fagnani D, Franchi R, Porta C, Pugliese P, Borgonovo K, Bertolini A, Duro M, Ardizzoia A, Filipazzi V, Isa L, Vergani C, Milani M, Cimminiello C; POLONORD Group..

Ann Oncol. 2007 Mar;18(3):551-5.

PMID:
17158773
20.

Primary thromboprophylaxis for cancer patients with central venous catheters--a reappraisal of the evidence.

Cunningham MS, White B, Hollywood D, O'Donnell J.

Br J Cancer. 2006 Jan 30;94(2):189-94. Review.

Supplemental Content

Support Center